Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964568 | Vaccine | 2014 | 5 Pages |
Abstract
The improved uptake of PEP and the high estimate of the effectiveness of HAV provides support for using HAV for PEP. The very high occurrence of hepatitis A among contacts who did not receive any PEP further highlights the importance of PEP in preventing hepatitis A infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Evan Freeman, Glenda Lawrence, Jeremy McAnulty, Sean Tobin, C. Raina MacIntyre, Siranda Torvaldsen,